Total planned funding: $156,508,686
Allocations
Countries/Regions
India | $156,508,686 |
Organizational Types
Unknown | $59,158,737 |
NGO | $45,726,064 |
Own Agency | $24,636,001 |
University | $15,532,112 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $1,750,000 |
Host Country Government Agency | $1,539,200 |
FBO | $1,100,000 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $63,790,750 |
Prevention | $38,843,617 |
Care | $19,780,605 |
Management and Operations | $18,743,051 |
Testing | $8,626,362 |
Treatment | $6,724,301 |
Budget Codes
OHSS: Health Systems Strengthening | $38,545,479 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,910,184 |
HVSI: Strategic Information | $21,226,079 |
HVMS: Management and Operations | $18,743,051 |
HBHC: Care: Adult Care and Support | $12,637,141 |
HVCT: Testing: HIV Testing and Counseling | $8,626,362 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,866,014 |
HTXS: Treatment: Adult Treatment | $6,319,030 |
HKID: Care: Orphans and Vulnerable Children | $4,515,239 |
HLAB: Laboratory Infrastructure | $4,019,192 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,555,455 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,461,723 |
HVTB: Care: TB/HIV | $2,076,918 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDCS: Care: Pediatric Care and Support | $551,307 |
PDTX: Treatment: Pediatric Treatment | $381,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$58,534,248
Countries/Regions
FHI 360:
$14,618,311
Countries/Regions
USG Aggregated Agencies:
$14,067,934
Countries/Regions
Voluntary Health Services:
$9,660,000
Countries/Regions